GC
FLNA

GMT Capital’s Filana Therapeutics FLNA Stock Holding History

GMT Capital’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$536K Hold
450,100
– – 0.03% 55
2026
Q1 		$761K Buy
+450,100
New +$927K 0.03% 60
2025
Q4 		– Sell
-450,100
Closed -$1.31M – 62
2025
Q3 		$1.31M Hold
450,100
– – 0.06% 51
2025
Q2 		$815K Hold
450,100
– – 0.03% 58
2025
Q1 		$675K Buy
+450,100
New +$1.14M 0.04% 58
2022
Q4 		– Sell
-115,100
Closed -$4.81M – 91
2022
Q3 		$4.81M Buy
+115,100
New +$3.11M 0.3% 50

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GMT Capital's FLNA Position: Q2 2026 in Review

GMT Capital held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 450,100 shares worth $536K. The position accounts for 0.03% of the portfolio, ranked #55.

GMT Capital first reported a position in FLNA in Q3 2022 and has held it in 6 quarters since. The position peaked at $4.81M in Q3 2022. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • GMT Capital held 450,100 shares of Filana Therapeutics worth $536K as of Q2 2026.
  • GMT Capital left its Filana Therapeutics share count unchanged in Q2 2026.
  • Filana Therapeutics made up 0.03% of GMT Capital's portfolio in Q2 2026, its #55 holding.
  • GMT Capital first reported a position in Filana Therapeutics in Q3 2022 and has held it in 6 quarters since.
  • GMT Capital's Filana Therapeutics position peaked at $4.81M in Q3 2022.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on GMT Capital's 13F filing for Q2 2026, filed 14 Aug 2026.